Malakoff Humanis is a provider of insurance products and services, focused on health and provident insurance. The company offers a range of solutions, including savings and retirement plans, tailored for businesses and self-employed individuals. In addition to its insurance offerings, Malakoff Humanis is committed to societal issues, particularly in areas such as cancer care, disability support, and promoting well-being for aging populations. Through its diverse services, the company aims to support individuals and organizations in managing their health and financial security.
Executive Director of the MH Innov' Investment Fund
14 past transactions
Surge
Seed Round in 2024
Surge is an immunological model capable of predicting postoperative infections. The company combines a single-cell assessment of the immune system before surgery with clinical data using a proprietary machine-learning algorithm. By analyzing the millions of immune cells in a small amount of blood, the platform can mimic surgical trauma in a test tube before surgery.
Betakorn
Acquisition in 2024
Betakorn is an operator of a holding company that specializes in the management and distribution of collective savings products.
Fasst
Venture Round in 2023
Fasst is involved in the creation, distribution, consulting, and connection of unique digital insurance solutions for brokers and insurers.
I-Virtual
Venture Round in 2023
i-Virtual is a deep-tech company focused on advanced sensing technologies that enhance artificial intelligence's ability to accurately perceive human biological signals. Its primary product, Saphere, is a video-based engine for measuring and processing vital signs, allowing for a seamless integration into various industries such as insurance, wellness, connected devices, and software-as-a-service providers. By enabling real-time, non-contact measurement of vital signs through a simple 30-second selfie, i-Virtual transforms AI into an intuitive partner for its users. This innovation not only makes vital sign monitoring more accessible but also empowers clients to achieve greater levels of personalization, efficiency, and engagement in everyday health and well-being.
Lifesquare
Acquisition in 2023
Lifesquare is a provider of insurance distribution services. They developed a platform that offers loan insurance compatible with all banks, online risk selection, electronic subscription, and personal advice over the phone.
Semeia
Venture Round in 2022
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in consultation. They use deep learning technologies to estimate the risk of the occurrence of an adverse event or disruption in the patients care pathway.
FACIL'iti
Venture Round in 2022
FACIL'iti provides a digital accessibility platform designed to enhance website usability for individuals with cognitive, motor, and perceptual impairments, as well as senior citizens. The platform adapts website displays to accommodate specific needs without requiring changes to the existing code, ensuring a seamless integration for web and intranet owners and developers. By offering its services on a subscription basis, FACIL'iti enables organizations to deliver a significantly improved and customized browsing experience for users with disabilities. This commitment to accessibility reflects a broader understanding of the importance of inclusivity in the digital landscape.
LegalPlace
Series B in 2022
LegalPlace provides legal services by offering customizable legal documents for individuals and businesses, along with a connection service to experienced lawyers. The company focuses on simplifying the process of establishing and managing a business by assisting clients in modifying statutes and drafting contracts according to current legal standards. LegalPlace enables users to obtain essential legal contracts efficiently and affordably, while also allowing them to manage both accounting and legal information in a centralized platform. This approach ensures that clients have access to the legal resources they need without unnecessary complexity or high costs.
Klaro
Seed Round in 2022
Klaro is a leading financial aid simulation platform in France, designed to help individuals and families access over 1,500 national, local, and regional aid programs. By streamlining the application process, Klaro enables employees to identify the financial assistance they are eligible for, maximizing their purchasing power with minimal effort and paperwork. The platform offers support throughout the application journey, ensuring users receive their aid directly in their bank accounts. Klaro addresses the issue of unclaimed benefits, recognizing that many households miss out on an average of 110 euros per month. To reach non-salaried populations, Klaro collaborates with associations, universities, and social housing organizations, making its services accessible to a broader audience.
Wandercraft
Series C in 2022
Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.
Xenothera
Series C in 2021
Xenothera is a biotechnology company focused on developing advanced immunological treatments through its innovative xenotherapy platform. The company specializes in creating hyperimmune polyclonal sera, which enhances passive immunotherapy for various medical applications, including immunomodulation and infectious diseases. Leveraging its expertise in animal genetics and immunology, Xenothera streamlines the development process by controlling all aspects, from the selection of immunogens to the purification of immunoglobulins. This comprehensive approach allows for accelerated market authorization, positioning Xenothera as a leader in transforming immunotherapeutic solutions for the medical community.
CetteFamille
Series A in 2020
CetteFamille is a French network that provides an economical alternative to traditional retirement homes by connecting seniors with professional and accredited families for shared housing. The platform facilitates the matching process, allowing elderly individuals and their families to find suitable caregivers nearby. Through its website, seniors can register to meet potential host families, while the CetteFamille team ensures that the requests are carefully studied to match each senior with the most appropriate family based on their specific needs. Additionally, CetteFamille offers follow-up services to assist with various administrative procedures, making the transition smoother for both seniors and their families. This approach aims to create a warm and personalized living arrangement that prioritizes the comfort and well-being of the elderly.
Squadeasy
Series A in 2019
Squadeasy is a company based in Paris, France, that specializes in creating a mobile and web-based platform aimed at enhancing employee engagement through running competitions. The platform enables firms to organize gamified workout challenges where employees can participate as teams, regardless of their physical fitness levels or geographical locations. By leveraging a connected and interactive approach, Squadeasy encourages physical activity and promotes sustainable mobility in the workplace. This innovative solution caters to a wide range of users, ensuring that all employees, whether seasoned athletes or beginners, can engage in a motivating exercise environment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.